Status:
TERMINATED
Improving Medication Adherence in ADHD Adolescents
Lead Sponsor:
Florida International University
Conditions:
ADHD
Eligibility:
All Genders
12-16 years
Phase:
NA
Brief Summary
Investigates whether a family-based intervention for adolescents with Attention Deficit Hyperactivity Disorder (ADHD) will improve adherence to prescribed medication regimen in adolescents with histor...
Detailed Description
We will evaluate a dual component family-based intervention for adolescents with ADHD to improve medication adherence (Supporting Teen Adherence and Responsibility; STAR). STAR pairs Motivational Inte...
Eligibility Criteria
Inclusion
- Diagnosis of ADHD; currently prescribed an FDA-approved medication for ADHD, history of medication nonadherence (taking less than 60% of prescribed doses); full scale Intelligence Quotient \>80, no current language delay and/or had no language delays before age 3.
Exclusion
- active medical conditions that could be worsened by stimulants (seizures, arrhythmias, hypertension) unless patient has clearance from primary specialist taking care of existing condition, pregnancy, Bipolar Disorder, schizophrenia, and/or other psychotic disorders, and diagnosis of current substance abuse or dependence (except nicotine), current psychotropic medication for conditions other than ADHD.
Key Trial Info
Start Date :
September 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT02271880
Start Date
September 1 2015
End Date
June 1 2016
Last Update
July 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Florida International University Center for Children and Families
Miami, Florida, United States, 33199